Suppr超能文献

抗凝患者的结肠镜息肉切除术。

Colonoscopic polypectomy in anticoagulated patients.

作者信息

Friedland Shai, Sedehi Daniel, Soetikno Roy

机构信息

Division of Gastroenterology, VA Palo Alto and Stanford University, 3801 Miranda Avenue, Palo Alto, CA 94304, USA.

出版信息

World J Gastroenterol. 2009 Apr 28;15(16):1973-6. doi: 10.3748/wjg.15.1973.

Abstract

AIM

To review our experience performing polypectomy in anticoagulated patients without interruption of anticoagulation.

METHODS

Retrospective chart review at the Veterans Affairs Palo Alto Health Care System. Two hundred and twenty five polypectomies were performed in 123 patients. Patients followed a standardized protocol that included stopping warfarin for 36 h to avoid supratherapeutic anticoagulation from the bowel preparation. Patients with lesions larger than 1 cm were generally rescheduled for polypectomy off warfarin. Endoscopic clips were routinely applied prophylactically.

RESULTS

One patient (0.8%, 95% CI: 0.1%-4.5%) developed major post-polypectomy bleeding that required transfusion. Two others (1.6%, 95% CI: 0.5%-5.7%) had self-limited hematochezia at home and did not seek medical attention. The average polyp size was 5.1 +/- 2.2 mm.

CONCLUSION

Polypectomy can be performed in therapeutically anticoagulated patients with lesions up to 1 cm in size with an acceptable bleeding rate.

摘要

目的

回顾我们在不中断抗凝治疗的情况下为抗凝患者进行息肉切除术的经验。

方法

在退伍军人事务部帕洛阿尔托医疗保健系统进行回顾性病历审查。对123例患者进行了225次息肉切除术。患者遵循标准化方案,包括停用华法林36小时,以避免肠道准备导致抗凝作用过强。对于病变大于1厘米的患者,通常重新安排在停用华法林后进行息肉切除术。常规预防性应用内镜夹。

结果

1例患者(0.8%,95%可信区间:0.1%-4.5%)发生息肉切除术后大出血,需要输血。另外2例患者(1.6%,95%可信区间:0.5%-5.7%)在家中出现自限性便血,未就医。息肉平均大小为5.1±2.2毫米。

结论

对于病变大小达1厘米的接受治疗性抗凝的患者,息肉切除术可以在可接受的出血率下进行。

相似文献

1
Colonoscopic polypectomy in anticoagulated patients.
World J Gastroenterol. 2009 Apr 28;15(16):1973-6. doi: 10.3748/wjg.15.1973.
2
Colonoscopy with polypectomy in anticoagulated patients.
Gastrointest Endosc. 2006 Jul;64(1):98-100. doi: 10.1016/j.gie.2006.02.030.
3
Post-polypectomy bleeding in hot-snare polypectomy of colonic polyps under continued warfarin or short interruption of direct oral anticoagulants.
Int J Colorectal Dis. 2019 Oct;34(10):1705-1712. doi: 10.1007/s00384-019-03373-4. Epub 2019 Aug 30.
5
Heparin bridge therapy and post-polypectomy bleeding.
World J Gastroenterol. 2016 Dec 7;22(45):10009-10014. doi: 10.3748/wjg.v22.i45.10009.
6
Risk factors for postpolypectomy bleeding in patients receiving anticoagulation or antiplatelet medications.
Gastrointest Endosc. 2018 Apr;87(4):1106-1113. doi: 10.1016/j.gie.2017.11.024. Epub 2017 Dec 6.
7
Colonoscopy with Polypectomy in Patients Taking Clopidogrel.
Gastroenterology Res. 2009 Aug;2(4):209-212. doi: 10.4021/gr2009.08.1308. Epub 2009 Jul 20.
8
Heparin-bridging therapy is associated with a high risk of post-polypectomy bleeding regardless of polyp size.
Dig Endosc. 2017 Jan;29(1):65-72. doi: 10.1111/den.12692. Epub 2016 Jul 28.
9
Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy.
J Thromb Haemost. 2009 Dec;7(12):1982-9. doi: 10.1111/j.1538-7836.2009.03598.x. Epub 2009 Aug 28.
10
Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases.
Gastrointest Endosc. 2004 Jan;59(1):44-8. doi: 10.1016/s0016-5107(03)02307-1.

引用本文的文献

4
Management of antiplatelet or anticoagulant therapy in endoscopy: A review of literature.
World J Gastrointest Endosc. 2020 Jun 16;12(6):172-192. doi: 10.4253/wjge.v12.i6.172.
5
Endoscopy in Patients on Antiplatelet Agents and Anticoagulants.
Curr Treat Options Gastroenterol. 2017 Jun;15(2):256-267. doi: 10.1007/s11938-017-0137-z.
6
Gastrointestinal endoscopy in patients receiving novel direct oral anticoagulants: results from the prospective Dresden NOAC registry.
J Gastroenterol. 2018 Feb;53(2):236-246. doi: 10.1007/s00535-017-1346-x. Epub 2017 May 10.
7
Gastrointestinal endoscopy in patients on anticoagulant therapy and antiplatelet agents.
Ann Gastroenterol. 2017;30(1):7-14. doi: 10.20524/aog.2016.0096. Epub 2016 Oct 7.
8
The Periprocedural Management of Anticoagulation and Platelet Aggregation Inhibitors in Endoscopic Interventions.
Dtsch Arztebl Int. 2016 Feb 26;113(8):129-35. doi: 10.3238/arztebl.2016.0129.

本文引用的文献

1
Colonoscopy is the preferred colorectal cancer screening method in a population-based program.
Endoscopy. 2008 Aug;40(8):650-5. doi: 10.1055/s-2008-1077350. Epub 2008 Jul 7.
2
Risk of thromboembolism with short-term interruption of warfarin therapy.
Arch Intern Med. 2008 Jan 14;168(1):63-9. doi: 10.1001/archinternmed.2007.23.
4
National survey of anticoagulation policy in endoscopy.
Eur J Gastroenterol Hepatol. 2007 Jan;19(1):51-6. doi: 10.1097/MEG.0b013e3280120eb5.
5
Colonoscopy with polypectomy in anticoagulated patients.
Gastrointest Endosc. 2006 Jul;64(1):98-100. doi: 10.1016/j.gie.2006.02.030.
8
Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases.
Gastrointest Endosc. 2004 Jan;59(1):44-8. doi: 10.1016/s0016-5107(03)02307-1.
9
Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals.
JAMA. 2003 Dec 10;290(22):2959-67. doi: 10.1001/jama.290.22.2959.
10
Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy.
Neurology. 2003 Oct 14;61(7):964-8. doi: 10.1212/01.wnl.0000086817.54076.eb.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验